BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 12939384)

  • 1. New developments in hyperphosphatemia management.
    Slatopolsky E
    J Am Soc Nephrol; 2003 Sep; 14(9 Suppl 4):S297-9. PubMed ID: 12939384
    [No Abstract]   [Full Text] [Related]  

  • 2. [Methods of correcting hyperphosphatemia in chronic renal failure and in dialysis (review)].
    Novikov AI
    Ter Arkh; 1997; 69(12):63-7. PubMed ID: 9503540
    [No Abstract]   [Full Text] [Related]  

  • 3. Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management.
    Block GA; Port FK
    Am J Kidney Dis; 2000 Jun; 35(6):1226-37. PubMed ID: 10845841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphate binders and management of hyperphosphataemia in end-stage renal disease.
    Savica V; Calò LA; Monardo P; Santoro D; Bellinghieri G
    Nephrol Dial Transplant; 2006 Aug; 21(8):2065-8. PubMed ID: 16766546
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cardiovascular calcification and accelerated atherosclerosis in chronic kidney disease].
    Cozzolino M; Butti A; Chiarelli G; Rocca-Rey L; Santagostino G; Gallieni M; Brancaccio D
    Ital Heart J Suppl; 2005 Jan; 6(1):25-8. PubMed ID: 15776728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Importance of the "adequate blood phosphorus" concept as a risk factor for hyperphosphatemia].
    Douthat WG; Alles A; Marinovich S; Tirado S; Peñalba A; Prudkin S
    Nefrologia; 2003; 23 Suppl 2():95-9. PubMed ID: 12778863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological control of secondary hyperparathyroidism in chronic hemodialysis patients: cinacalcet is coming to Japan.
    Iseki K
    Expert Opin Pharmacother; 2008 Mar; 9(4):601-10. PubMed ID: 18312161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [News in the treatment of hyperphosphatemia].
    Kes P; Baśić-Jukić N
    Lijec Vjesn; 2004; 126(9-10):271-3. PubMed ID: 15918327
    [No Abstract]   [Full Text] [Related]  

  • 9. Resolution of secondary hyperparathyroidism after cadaveric renal allograft.
    Varghese Z; Wills MR; Ahmed KY; Fairney A; Baillod RA; Tatler GL; Hopewell JP; Moorhead JF
    Proc Eur Dial Transplant Assoc; 1975; 11():261-7. PubMed ID: 1105549
    [No Abstract]   [Full Text] [Related]  

  • 10. [New therapy strategies in secondary hyperparathyroidism on dialysis (I): new concepts, new treatments].
    Bover J; Ortiz-Herbener F; Ballarín J; Andrés E; Barceló P
    Nefrologia; 2005; 25 Suppl 2():100-8. PubMed ID: 16050412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic indications obtained from short- and medium-term biohumoral changes after parathyroidectomy].
    Sforzini S; Viganò MR; Rosa M; Redaelli B
    Minerva Med; 1985 Mar; 76(9-10):393-6. PubMed ID: 3982696
    [No Abstract]   [Full Text] [Related]  

  • 12. Re-evaluating our approach to calcium and phosphorus management in dialysis patients.
    Keith DS
    Am J Kidney Dis; 2001 Jun; 37(6):1331-3. PubMed ID: 11382711
    [No Abstract]   [Full Text] [Related]  

  • 13. Slowing the progression of vascular calcification in hemodialysis.
    Chertow GM
    J Am Soc Nephrol; 2003 Sep; 14(9 Suppl 4):S310-4. PubMed ID: 12939387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Extra-osseous calcification and its regression after treatment in a case of long-term hemodialysis].
    Kuhlencordt F; Augustin HJ; Kruse HP
    Dtsch Med Wochenschr; 1970 Oct; 95(42):2122-5. PubMed ID: 4990903
    [No Abstract]   [Full Text] [Related]  

  • 15. [Renal osteodystrophy and its possible correction in patients on chronic hemodialysis].
    Rozental' RL; Babarykin DA; Tikhomirova TE; Il'inskiĭ IM; Chernevskis KhK
    Ter Arkh; 1986; 58(1):105-8. PubMed ID: 3961679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Metastatic calcinosis in patients on long-term dialysis].
    Janda J; Sefrna F; Zichová M
    Cesk Patol; 1987 Dec; 23(4):204-10. PubMed ID: 3442839
    [No Abstract]   [Full Text] [Related]  

  • 17. [Posttransplant regression of uremic tumoral calcinosis].
    de Alarcón RM; Palomares M; Marfil A; Asensio C
    Nefrologia; 2007; 27(3):378-81. PubMed ID: 17725459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of bone and mineral related disorders in chronic kidney disease: key role of hyperphosphatemia.
    Román-García P; Carrillo-López N; Cannata-Andía JB
    J Ren Care; 2009 Mar; 35 Suppl 1():34-8. PubMed ID: 19222729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumoral calcinosis in patients on hemodialysis. Case report and review of the literature.
    Pecovnik-Balon B; Kramberger S
    Am J Nephrol; 1997; 17(1):93-5. PubMed ID: 9057960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Secondary hyperparathyroidism in renal insufficiency. Prevention and therapy].
    Malluche HH; Ritz E
    MMW Munch Med Wochenschr; 1976 Jan; 118(5):129-30. PubMed ID: 814442
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.